Clinical efficacy of neoadjuvant chemotherapy regimens FLEEOX vs. XELOX in patients with initially unresectable advanced gastric cancer: a propensity score analysis

PURPOSE: This study was designed to assess the effectiveness of FLEEOX (5-Fu, leucovorin, etoposide, oxaliplatin, and epirubicin) compared with XELOX (capecitabine and oxaliplatin) as neoadjuvant chemotherapy (NAC) for initially unresectable advanced gastric cancer (AGC). METHODS: This study reviewe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Chen, Jun, He, Qi, Ji, Xiang, Wang, Xulin, Fan, Chaogang, Li, Guoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689733/
https://www.ncbi.nlm.nih.gov/pubmed/29156843
http://dx.doi.org/10.18632/oncotarget.19004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689733/
https://www.ncbi.nlm.nih.gov/pubmed/29156843
http://dx.doi.org/10.18632/oncotarget.19004

Ejemplares similares